TrialNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2008

A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia.

Donald C Goff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.